What are the causes of chronic kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Chronic Kidney Disease

The two dominant causes of CKD globally are diabetes mellitus and hypertension/atherosclerosis, accounting for the majority of cases in high-income, middle-income, and many low-income countries 1, 2. However, the etiology of CKD is often multifactorial and in many patients remains unidentified 3.

Primary Causes

Diabetic Kidney Disease

Diabetic kidney disease is the single largest cause of CKD and end-stage renal disease in the United States and most developed nations 4, 3. It affects 20-40% of patients with diabetes 5, 6. In diabetes, CKD can manifest in several patterns:

  • Classical diabetic nephropathy: Characterized by mesangial expansion, diffuse or nodular glomerulosclerosis with Kimmelstiel-Wilson lesions, and arteriolar sclerohyalinosis 7
  • Non-classical presentations: Up to half of diabetic patients with reduced kidney function have normal urinary protein levels, representing alternative causes such as hypertensive nephrosclerosis or diffuse microvascular atherosclerosis 7

Hypertension and Vascular Disease

Hypertension is both a cause and complication of CKD 3. Kidney damage from hypertension or diffuse microvascular atherosclerosis commonly presents with reduced renal function and urinary protein in the normal or microalbumin range 7.

Secondary and Less Common Causes

Glomerular Diseases

  • Primary glomerulonephritis (e.g., membranous nephropathy, IgA nephropathy)
  • Secondary glomerular diseases from systemic conditions (e.g., lupus nephritis) 7

Genetic/Hereditary Conditions

  • Autosomal dominant polycystic kidney disease (ADPKD) 8
  • Autosomal dominant tubulointerstitial kidney disease caused by mutations in:
    • UMOD (uromodulin)
    • MUC1 (mucin-1)
    • REN (renin)
    • HNF1B (hepatocyte nuclear factor 1b) 8

Tubulointerstitial Diseases

  • Chronic interstitial nephritis
  • Obstructive uropathy
  • Reflux nephropathy 3

Vascular Diseases

  • Renal artery stenosis
  • Ischemic nephropathy 3

Modifiable Risk Factors

Beyond the primary disease causes, several modifiable factors contribute to CKD development and progression:

  • Smoking 9
  • Obesity 9
  • Metabolic syndrome 9
  • Hyperlipidemia 9
  • Exposure to nephrotoxins: Heavy metals, excessive alcohol, analgesic medications 9
  • Acute kidney injury history 9

Emerging and Regional Causes

CKD of Unknown Etiology (CKDu)

Increasingly reported from agricultural communities in Central America, Sri Lanka, and India, particularly affecting young male adults of lower socioeconomic status. Potential contributing factors include:

  • Silica, arsenic, and fluoride exposure
  • Heat stress and dehydration
  • Mycotoxins (aflatoxins, ochratoxins)
  • Pesticides (HCH, Endosulfan, Alachlor, Pendimethalin)
  • Infections (Hantavirus, Leptospirosis) 10

Infectious Causes

  • Hepatitis C virus
  • HIV infection 9

Clinical Pearls for Identifying Etiology

When evaluating CKD etiology, establish the cause using clinical context, personal and family history, social and environmental factors, medications, physical examination, laboratory measures, imaging, and genetic and pathologic diagnosis 11.

Red Flags Suggesting Non-Diabetic Causes in Diabetic Patients:

  • Diabetes duration <5 years (especially type 1)
  • Active urine sediment (red or white blood cell casts)
  • Persistent hematuria
  • Rapidly falling eGFR (≥5 mL/min/1.73 m² loss per year)
  • Low eGFR with little or no proteinuria
  • Extreme proteinuria (>6 g/day)
  • Absence of diabetic retinopathy
  • Family history of non-diabetic renal disease 7, 6

These atypical presentations warrant nephrology referral and consideration of kidney biopsy 7, 6.

Sociodemographic Considerations

Race, gender, age, and family history significantly influence CKD risk:

  • African-American descent confers higher risk
  • Older age increases susceptibility
  • Low birth weight is a risk factor
  • Family history of kidney disease 9

The poorest populations globally face the highest CKD risk, with substantial disparities in access to care and treatment 2.

Related Questions

What is the difference between stage 3b chronic kidney disease and stage 4 chronic kidney disease?
How should I treat a chronic kidney disease patient not yet on dialysis who has a diastolic blood pressure of 29 mm Hg?
What is the recommended management for chronic kidney disease, including staging, blood pressure targets, ACE inhibitor or ARB therapy, SGLT2 inhibitor use, dietary recommendations, monitoring, and referral criteria?
What are the common symptoms of assisted kidney disease (e.g., chronic kidney disease requiring dialysis or transplantation)?
What are the indications for initiating fluid restriction in patients with chronic kidney disease?
What are the systemic therapy principles for metastatic renal cell carcinoma?
What is the recommended starting dose and titration schedule for sacubitril/valsartan (ARNI) in a patient with heart failure with reduced ejection fraction and chronic kidney disease stage 3a (eGFR ≈ 45 mL/min/1.73 m²)?
What are the side effects of stimulant medications such as methylphenidate, amphetamine salts, dexamfetamine, and lisdexamfetamine?
For patients able to exercise with a normal resting electrocardiogram, is an exercise treadmill stress test preferred over a two‑dimensional echocardiogram with Doppler as the initial screening test for coronary artery disease?
What are the recommended starting dose, titration schedule, common adverse effects, and monitoring guidelines for dexamphetamine in adults and pediatric patients?
What protocol should be used to manage pregnant patients admitted to the hospital according to UK and US guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.